Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
Q2 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
Q3 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
Q4 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
Q1 2026 | 1 | -$0.17 | -$0.17 | -$0.17 |
Organovo Holdings, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $-0.14 earnings per share for the quarter, topping analysts' consensus estimates of $-0.26 by $0.12. The company had revenue of 30,000 for the quarter and had revenue of 109,000 for the year. Organovo Holdings, Inc. has generated $-2 earnings per share over the last year ($-1.6 diluted earnings per share) and currently has a price-to-earnings ratio of -0.51. Organovo Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/08/2024 | Q2 2024 | -$0.26 | -$0.14 | 0.12 | $41,000 | $30,000 |
08/05/2024 | Q1 2024 | -$0.38 | -$0.23 | 0.15 | $39,000 | $39,000 |
07/26/2024 | Q4 2023 | -$0.30 | $29,000 | |||
02/08/2024 | Q3 2023 | -$0.41 | -$0.40 | 0.01 | $5,000 | |
11/09/2023 | Q2 2023 | -$0.43 | -$0.46 | -0.03 | $75.00 M | $0 |
08/10/2023 | Q1 2023 | -$0.46 | $75,000 | |||
07/13/2023 | Q4 2022 | -$0.80 | $162,000 | |||
02/09/2023 | Q3 2022 | -$0.36 | $131,000 | |||
11/10/2022 | Q2 2022 | -$0.37 | $77,000 | |||
08/11/2022 | Q1 2022 | -$0.37 | $0 | |||
06/10/2022 | Q4 2021 | -$0.22 | $1.50 M | |||
02/14/2022 | Q3 2021 | -$0.40 | $0 | |||
11/08/2021 | Q2 2021 | -$0.40 | $0 | |||
08/06/2021 | Q1 2021 | -$0.29 | $0 | |||
06/15/2021 | Q4 2020 | -$0.40 | $0 | |||
02/08/2021 | Q3 2020 | -$0.37 | $0 | |||
11/05/2020 | Q2 2020 | -$1.36 | $0 | |||
08/10/2020 | Q1 2020 | -$0.42 | $0 | |||
05/28/2020 | Q4 2019 | -$0.42 | $258,000 | |||
02/10/2020 | Q3 2019 | -$0.52 | $298,000 |
Organovo Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates.
In the previous quarter, Organovo Holdings, Inc. (:ONVO) reported $-0.14 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.26 by $0.12.
The conference call for Organovo Holdings, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Organovo Holdings, Inc.'s latest earnings report can be read online.
Organovo Holdings, Inc. (:ONVO) has a recorded annual revenue of $109,000.
Organovo Holdings, Inc. (:ONVO) has a recorded net income of $109,000. Organovo Holdings, Inc. has generated $-1.6 earnings per share over the last four quarters.
Organovo Holdings, Inc. (:ONVO) has a price-to-earnings ratio of -0.51 and price/earnings-to-growth ratio is -0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED